source
- City Therapeutics completes $200 million IPO, earmarks funds for RNAi therapiesCity Therapeutics, based in Cambridge, Massachusetts, launched an IPO raising $200 million, exceeding its original target of 9.7 million shares at $17-$19 per share. The company sold 11.1 million…
- Patients stop meds for deeper reasons than forgetfulness, pharmacist saysMarcela Gottschald, a pharmacist and journalist, reflects on her early assumption that patients missed doses mainly because they forgot, were frustrated by side effects, or lacked understanding of…